Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
- PMID: 3951539
- DOI: 10.1038/319675a0
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
Abstract
Metazoan organisms may discriminate between self and non-self not only by the presence of foreign antigens but also by the absence of normal self markers. Mammalian adaptive immune responses use the first strategy, with the additional requirement that foreign antigens are recognized in the context of self-major histocompatibility complex (MHC) products at the cell surface. Aberrant cells which fail to express MHC products adequately can therefore avoid detection. A more primitive but complementary defence system, eliminating such cells on the basis of absent self-markers, is suggested by a re-interpretation of phenomena associated with metastasis and natural resistance. We now show that murine lymphoma cells selected for loss of H-2 expression are less malignant after low-dose inoculation in syngeneic hosts than are wild-type cells, and that the rejection of such cells is non-adaptive. On the basis of our data, we suggest that natural killer cells are effector cells in a defence system geared to detect the deleted or reduced expression of self-MHC.
Similar articles
-
Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.J Immunol. 1988 Jan 15;140(2):671-8. J Immunol. 1988. PMID: 3335786
-
MHC gene control of the natural killer system at the level of the target and the host.Semin Cancer Biol. 1991 Oct;2(5):295-309. Semin Cancer Biol. 1991. PMID: 1773046 Review.
-
Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.Cancer Res. 1995 May 1;55(9):1911-6. Cancer Res. 1995. PMID: 7728758
-
Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.J Immunol. 1993 Jul 1;151(1):244-55. J Immunol. 1993. PMID: 8326126
-
Receptors that turn on and turn off natural killer cells.J Heart Lung Transplant. 1996 Jul;15(7):675-83. J Heart Lung Transplant. 1996. PMID: 8820783 Review.
Cited by
-
The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.Front Immunol. 2013 Jan 4;3:402. doi: 10.3389/fimmu.2012.00402. eCollection 2012. Front Immunol. 2013. PMID: 23316193 Free PMC article.
-
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.J Exp Med. 2012 Dec 17;209(13):2351-65. doi: 10.1084/jem.20120944. Epub 2012 Dec 3. J Exp Med. 2012. PMID: 23209317 Free PMC article.
-
A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.Oncotarget. 2016 Jun 7;7(23):34582-98. doi: 10.18632/oncotarget.9149. Oncotarget. 2016. PMID: 27153556 Free PMC article.
-
RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells.Cancer Cell Int. 2015 Jun 5;15:57. doi: 10.1186/s12935-015-0209-x. eCollection 2015. Cancer Cell Int. 2015. PMID: 26146488 Free PMC article.
-
Engineering antiphagocytic biomimetic drug carriers.Ther Deliv. 2013 Jul;4(7):825-39. doi: 10.4155/tde.13.54. Ther Deliv. 2013. PMID: 23883126 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials